Lexaria Bioscience Corp. (LEXX) › Total LiabilitiesLexaria Bioscience Corp. (LEXX) — Total LiabilitiesAnnual figures by fiscal year, from SEC filings.2010: $1.12M2011: $1.68M2012: $1.77M2013: $1.47M2014: $918.0K2015: $55.1K2016: $478.9K2017: $92.3K2018: $43.6K2019: $184.5K2020: $346.0K2021: $203.3K2022: $201.4K2023: $403.9K2024: $1.21M2025: $1.57M$1.57M2010Total Liabilities (USD)2025Fiscal YearTotal LiabilitiesChange YoY2025$1.57M+30.1%2024$1.21M+199.3%2023$403.9K+100.5%2022$201.4K-0.9%2021$203.3K-41.2%2020$346.0K+87.5%2019$184.5K+322.8%2018$43.6K-52.7%2017$92.3K-80.7%2016$478.9K+768.7%2015$55.1K-94.0%2014$918.0K-37.7%2013$1.47M-16.7%2012$1.77M+5.5%2011$1.68M+49.2%2010$1.12M—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share